Title: Expression of ERCC1, p53, and Class III β-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer: Results From an Immunohistochemical Study
Authors: Vandenput, Ingrid ×
Capoen, An
Coenegrachts, Lieve
Verbist, Godelieve
Moerman, Philippe
Vergote, Ignace
Amant, Frédéric #
Issue Date: Aug-2011
Publisher: Blackwell Scientific Publications
Series Title: International Journal of Gynecological Cancer vol:21 issue:6 pages:1071-7
Abstract: : In non-small cell lung cancer, expression of excision repair cross-complementation group 1 (ERCC1) and p53 correlates with platinum resistance and class III β-tubulin with resistance to taxanes. The potential to personalize treatment in endometrial cancer remains uninvestigated.
ISSN: 1048-891X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gynaecological Oncology
Section Woman - Miscellaneous (-)
Translational Cell & Tissue Research
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science